These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37241228)

  • 1. The Role of ROR1 in Chemoresistance and EMT in Endometrial Cancer Cells.
    Lee KJ; Kim NH; Kim HS; Kim Y; Lee JJ; Kim JH; Cho HY; Jeong SY; Park ST
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241228
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.
    Cui B; Zhang S; Chen L; Yu J; Widhopf GF; Fecteau JF; Rassenti LZ; Kipps TJ
    Cancer Res; 2013 Jun; 73(12):3649-60. PubMed ID: 23771907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-379-5p inhibits proliferation and invasion of the endometrial cancer cells by inhibiting expression of ROR1.
    Liang M; Chen H; Min J
    Acta Biochim Pol; 2021 Jun; 68(4):659-665. PubMed ID: 34115460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.
    Liu D; Gunther K; Enriquez LA; Daniels B; O'Mara TA; Tang K; Spurdle AB; Ford CE
    Sci Rep; 2020 Aug; 10(1):13906. PubMed ID: 32807831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
    Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
    Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1.
    Cao J; Wang X; Dai T; Wu Y; Zhang M; Cao R; Zhang R; Wang G; Jiang R; Zhou BP; Shi J; Kang T
    Theranostics; 2018; 8(10):2739-2751. PubMed ID: 29774072
    [No Abstract]   [Full Text] [Related]  

  • 7. miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
    Tan H; He Q; Gong G; Wang Y; Li J; Wang J; Zhu D; Wu X
    Int J Oncol; 2016 Jan; 48(1):181-90. PubMed ID: 26575700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR‑30a inhibits epithelial‑mesenchymal transition and metastasis in triple‑negative breast cancer by targeting ROR1.
    Wang X; Qiu H; Tang R; Song H; Pan H; Feng Z; Chen L
    Oncol Rep; 2018 Jun; 39(6):2635-2643. PubMed ID: 29693179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROR1 is highly expressed in circulating tumor cells and promotes invasion of pancreatic cancer.
    Xu GL; Shen J; Xu YH; Wang WS; Ni CF
    Mol Med Rep; 2018 Dec; 18(6):5087-5094. PubMed ID: 30272313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atractylenolide II reverses the influence of lncRNA XIST/miR-30a-5p/ROR1 axis on chemo-resistance of colorectal cancer cells.
    Zhang R; Wang Z; Yu Q; Shen J; He W; Zhou D; Yu Q; Fan J; Gao S; Duan L
    J Cell Mol Med; 2019 May; 23(5):3151-3165. PubMed ID: 30907503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROR1 Expression and Its Functional Significance in Hepatocellular Carcinoma Cells.
    Cetin M; Odabas G; Douglas LR; Duriez PJ; Balcik-Ercin P; Yalim-Camci I; Sayan AE; Yagci T
    Cells; 2019 Mar; 8(3):. PubMed ID: 30832318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of receptor tyrosine kinase-like orphan receptor 1 in preeclampsia placenta inhibits human trophoblast cell proliferation, migration, and invasion by PI3K/AKT/mTOR pathway accommodation.
    Chen J; Yue C; Xu J; Zhan Y; Zhao H; Li Y; Ye Y
    Placenta; 2019 Jul; 82():17-24. PubMed ID: 31174622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
    Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
    J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIR-379-5p Expression in Endometrial Cancer and Its Correlation with ROR1 Expression.
    Mosaad H; Abdelrahman AE; Abdullatif A; Lashin ME; Ramadan MSH; El-Azony A; Hussien MHS
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):239-248. PubMed ID: 36708573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP/BRD4-controlled ROR1 promotes tumor-initiating cells and hyperproliferation in pancreatic cancer.
    Yamazaki M; Hino S; Usuki S; Miyazaki Y; Oda T; Nakao M; Ito T; Yamagata K
    EMBO J; 2023 Jul; 42(14):e112614. PubMed ID: 37096681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SETD8 induces stemness and epithelial-mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression.
    Liu M; Shi Y; Hu Q; Qin Y; Ji S; Liu W; Zhuo Q; Fan G; Ye Z; Song C; Yu X; Xu X; Xu W
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1614-1624. PubMed ID: 34599596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
    Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
    Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA ROR1-AS1 induces tumorigenesis of colorectal cancer by affecting Wnt/β-catenin signaling pathway.
    Wang W; Zheng W; Zhang L; Li K
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment acidity modulates ROR1 to promote epithelial-mesenchymal transition and hepatocarcinoma metastasis.
    Meng X; Xu Y; Ning X
    J Cell Sci; 2021 Apr; 134(7):. PubMed ID: 33648935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the prognostic significance of receptor tyrosine kinase-like orphan receptor 1 (ROR1) in lung carcinoma and its relation to lymphangiogenesis and epithelial mesenchymal transition.
    Heabah NAE; Darwish SA; Eid AM
    Pathol Res Pract; 2023 Aug; 248():154703. PubMed ID: 37481855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.